Overview

A Study of A-101 Topical Solution Administered Twice a Week in Subjects With Common Warts

Status:
Completed
Trial end date:
2018-03-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the effectiveness of A-101 compared to Vehicle when applied to 1 Target common wart on the trunk or extremities twice a week.
Phase:
Phase 2
Details
Lead Sponsor:
Aclaris Therapeutics, Inc.
Treatments:
Pharmaceutical Solutions